ATE322278T1 - Verbindungen aus phyllanthus zur prävention und/oder behandlung von erkrankungen im zusammenhang mit einem retrovirus - Google Patents
Verbindungen aus phyllanthus zur prävention und/oder behandlung von erkrankungen im zusammenhang mit einem retrovirusInfo
- Publication number
- ATE322278T1 ATE322278T1 AT01986262T AT01986262T ATE322278T1 AT E322278 T1 ATE322278 T1 AT E322278T1 AT 01986262 T AT01986262 T AT 01986262T AT 01986262 T AT01986262 T AT 01986262T AT E322278 T1 ATE322278 T1 AT E322278T1
- Authority
- AT
- Austria
- Prior art keywords
- retrovirus
- phyllanthus
- prevention
- treatment
- compounds
- Prior art date
Links
- 241001430294 unidentified retrovirus Species 0.000 title abstract 5
- 241001130943 Phyllanthus <Aves> Species 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 229920002824 gallotannin Polymers 0.000 abstract 4
- TUSDEZXZIZRFGC-XIGLUPEJSA-N corilagin Chemical compound O([C@H]1[C@H](O)[C@H]2OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC[C@@H](O1)[C@H]2O)C(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-XIGLUPEJSA-N 0.000 abstract 3
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 abstract 2
- 239000003112 inhibitor Substances 0.000 abstract 2
- JMGCAHRKIVCLFW-UHFFFAOYSA-N 1-O-Galloylcastalagin Natural products Oc1cc(cc(O)c1O)C(=O)OC2C3OC(=O)c4c2c(O)c(O)c(O)c4c5c(O)c(O)c(O)c6c5C(=O)OC3C7OC(=O)c8cc(O)c(O)c(O)c8c9c(O)c(O)c(O)cc9C(=O)OCC7OC(=O)c%10cc(O)c(O)c(O)c6%10 JMGCAHRKIVCLFW-UHFFFAOYSA-N 0.000 abstract 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 abstract 1
- 229920002786 Corilagin Polymers 0.000 abstract 1
- JQQBXPCJFAKSPG-SVYIMCMUSA-N Geraniin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2[C@@H]3OC(=O)C=4C=C(O)C(O)=C5O[C@@]6(O)C(=O)C=C([C@@H](C5=4)C6(O)O)C(=O)O[C@H]4[C@@H]3OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC[C@H]4O2)=C1 JQQBXPCJFAKSPG-SVYIMCMUSA-N 0.000 abstract 1
- 229920000061 Geraniin Polymers 0.000 abstract 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 244000173207 Phyllanthus amarus Species 0.000 abstract 1
- CPWYQGWOJMNXGJ-UHFFFAOYSA-N corilagin Natural products OC1C2COC(=O)c3c(O)c(O)c(O)c(O)c3c4c(O)c(O)c(O)c(O)c4C(=O)OC1C(O)C(OC(=O)c5cc(O)c(O)c(O)c5)O2 CPWYQGWOJMNXGJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920001968 ellagitannin Polymers 0.000 abstract 1
- JMGCAHRKIVCLFW-CNWXVVPTSA-N ellagitannin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2C3=C4C(=O)O[C@@H]2[C@@H]2[C@@H]5OC(=O)C6=CC(O)=C(O)C(O)=C6C6=C(O)C(O)=C(O)C=C6C(=O)OC[C@H]5OC(=O)C5=CC(O)=C(O)C(O)=C5C=5C(O)=C(O)C(O)=C(C=5C(=O)O2)C4=C(O)C(O)=C3O)=C1 JMGCAHRKIVCLFW-CNWXVVPTSA-N 0.000 abstract 1
- GJMUCSXZXBCQRZ-UHFFFAOYSA-N geraniin Natural products Oc1cc(cc(O)c1O)C(=O)OC2OC3COC(=O)c4cc(O)c(O)c(O)c4c5cc(C(=O)C67OC3C(O6)C2OC(=O)c8cc(O)c(O)c9OC%10(O)C(C(=CC(=O)C%10(O)O)C7=O)c89)c(O)c(O)c5O GJMUCSXZXBCQRZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00121852 | 2000-10-06 | ||
EP01114008 | 2001-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE322278T1 true ATE322278T1 (de) | 2006-04-15 |
Family
ID=26071484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01986262T ATE322278T1 (de) | 2000-10-06 | 2001-10-05 | Verbindungen aus phyllanthus zur prävention und/oder behandlung von erkrankungen im zusammenhang mit einem retrovirus |
Country Status (10)
Country | Link |
---|---|
US (1) | US20040161477A1 (de) |
EP (1) | EP1333848B1 (de) |
JP (1) | JP2004513092A (de) |
AT (1) | ATE322278T1 (de) |
AU (1) | AU2002220594A1 (de) |
CA (1) | CA2424869A1 (de) |
DE (1) | DE60118592T2 (de) |
ES (1) | ES2261507T3 (de) |
PT (1) | PT1333848E (de) |
WO (1) | WO2002028403A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE275413T1 (de) | 2000-10-06 | 2004-09-15 | Phytrix Ag | Verfahren zur herstellung von phyllanthusextrakten |
EP2116253A1 (de) | 2008-05-07 | 2009-11-11 | Phytrix JV, LLC | Neuartiger Phyllanthus-Extrakt |
WO2011085454A1 (en) * | 2010-01-18 | 2011-07-21 | Katholieke Universiteit Leuven K.U.Leuven R&D | Gp120 -binding benzene compounds and saccharide compounds |
KR101604347B1 (ko) | 2013-07-01 | 2016-03-17 | 한국생명공학연구원 | 피스타시아 웨인마니폴리아 추출물 또는 이의 분획물을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물 |
CN103480178B (zh) * | 2013-09-30 | 2016-09-28 | 新疆大学 | 一种亚临界水提取雪菊中活性成分的方法 |
CN103976356B (zh) * | 2014-05-07 | 2015-08-26 | 王浩 | 一种减肥食品及其制备方法 |
CN110665002B (zh) * | 2019-10-29 | 2023-01-24 | 信阳市动物疫病预防控制中心 | 一种用于防治牛病毒性腹泻的抗体制剂及其制备方法 |
CN111658631A (zh) * | 2020-06-11 | 2020-09-15 | 广东盛普生命科技有限公司 | 没食子酸及其衍生物和结构类似物在制备抗冠状病毒药物方面的应用 |
CN112022867B (zh) * | 2020-06-18 | 2022-05-13 | 浙江省疾病预防控制中心 | 老鹳草素在制备抗新型冠状病毒药中的应用 |
EP3954379A1 (de) * | 2020-08-12 | 2022-02-16 | HFM - Hybrid Fusion Medicals, GmbH | Zusammensetzungen mit phyllanthus-extrakt zur verwendung in der behandlung oder vorbeugung einer sars-cov-2-infektion und/oder mindestens eines symptoms von covid-19 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US28754A (en) * | 1860-06-19 | Congress boot | ||
US33275A (en) * | 1861-09-10 | Improved pipe-joi-nt | ||
US4388457A (en) * | 1982-02-11 | 1983-06-14 | University Patents, Inc. | Phyllanthostatin compounds |
US4673575A (en) * | 1985-04-26 | 1987-06-16 | Fox Chase Cancer Center | Composition, pharmaceutical preparation and method for treating viral hepatitus |
US4937074A (en) * | 1988-03-29 | 1990-06-26 | Fox Chase Cancer Center | Method of treating retrovirus infection |
WO1990004968A1 (en) * | 1988-10-31 | 1990-05-17 | University Of North Carolina At Chapel Hill | Inhibition of human retroviruses |
US5854233A (en) * | 1993-09-08 | 1998-12-29 | Pharmacy And Therapeutic Advisory Consultancy Ltd. | Method of treating liver disease and like indications with vasodilating agents |
US5529778A (en) * | 1994-09-13 | 1996-06-25 | Rohatgi; Surendra | Ayurvedic composition for the prophylaxis and treatment of AIDS, flu, TB and other immuno-deficiencies and the process for preparing the same |
US5571441A (en) * | 1994-11-01 | 1996-11-05 | The Procter & Gamble Company | Nutrient supplement compositions providing physiologic feedback |
US5648089A (en) * | 1995-07-03 | 1997-07-15 | Shawkat; Tarek | Extract solution and herbal mixture for treatment of hepatitis |
US6136316A (en) * | 1996-04-17 | 2000-10-24 | Dabur Research Foundation | Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection |
DE19919585A1 (de) * | 1999-04-29 | 2000-12-07 | Cmi Ag | Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen |
-
2001
- 2001-10-05 ES ES01986262T patent/ES2261507T3/es not_active Expired - Lifetime
- 2001-10-05 DE DE60118592T patent/DE60118592T2/de not_active Expired - Lifetime
- 2001-10-05 US US10/398,379 patent/US20040161477A1/en not_active Abandoned
- 2001-10-05 EP EP01986262A patent/EP1333848B1/de not_active Expired - Lifetime
- 2001-10-05 AT AT01986262T patent/ATE322278T1/de not_active IP Right Cessation
- 2001-10-05 WO PCT/EP2001/011524 patent/WO2002028403A1/en active IP Right Grant
- 2001-10-05 PT PT01986262T patent/PT1333848E/pt unknown
- 2001-10-05 AU AU2002220594A patent/AU2002220594A1/en not_active Abandoned
- 2001-10-05 CA CA002424869A patent/CA2424869A1/en not_active Abandoned
- 2001-10-05 JP JP2002532227A patent/JP2004513092A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2261507T3 (es) | 2006-11-16 |
DE60118592D1 (de) | 2006-05-18 |
DE60118592T2 (de) | 2007-05-16 |
JP2004513092A (ja) | 2004-04-30 |
CA2424869A1 (en) | 2002-04-11 |
EP1333848A1 (de) | 2003-08-13 |
EP1333848B1 (de) | 2006-04-05 |
WO2002028403A1 (en) | 2002-04-11 |
AU2002220594A1 (en) | 2002-04-15 |
US20040161477A1 (en) | 2004-08-19 |
PT1333848E (pt) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998001144A2 (en) | Antiviral agents from plant extracts and use for treatment of viral infections | |
CA2271622A1 (en) | Antiviral agents from plant extracts and use for treatment of viral infections | |
ATE264914T1 (de) | Antivirale proteine, dafür kodierende dna, und deren verwendung | |
ATE322278T1 (de) | Verbindungen aus phyllanthus zur prävention und/oder behandlung von erkrankungen im zusammenhang mit einem retrovirus | |
RU2329050C2 (ru) | Комбинация ингибиторов цитохром-р450-зависимых протеаз | |
MX9304837A (es) | Peptidos capaces de inhibir la actividad de proteasa vih, su preparacion y su uso terapeutico. | |
RU2007104774A (ru) | Комбинация анти-вич ингибиторов обратной транскриптазы и протеазы | |
CA2163348A1 (en) | Calanolide and Related Antiviral Compounds, Compositions, and Uses Thereof | |
EP4321217A3 (de) | Substituierte pyridotriazinverbindungen und verwendungen davon | |
BR9911523A (pt) | Composto de efavirenz, composição farmacêutica, método para inibição da replicação por uma transcriptase reversa viralmente codificada e método para tratamento da infecção do hiv | |
ATE182789T1 (de) | Arzneimittelzusammensetzung zur prophylaxe und behandlung vorzeitigen samenergusses | |
EP0681578A1 (de) | Gegen virussen wirksam naphtochinon verbindungen, zusammensetzungen und deren verwendungen. | |
DE69325020D1 (de) | Calanolid antivirale verbindungen, zusammensetzungen und verwendungen davon | |
DE3872881D1 (de) | Arzneimittelzusammensetzung zur vorbeugung und behandlung bakterieller und viraler krankheiten. | |
NO20003866D0 (no) | Urte-antiviralt middel | |
FR2296426A1 (fr) | Elixir | |
ATE308333T1 (de) | Pharmazeutische zusammensetzung zur behandlung von verfrühter ejakulation und/oder von überempfindlichkeit der sexuellen stimulierung | |
Narahari et al. | LE-like erythema and periungual telangiectasia among coffee plantation workers. | |
DK0384308T3 (da) | Ekstrakt-lægemiddel | |
DE60033699D1 (de) | Kräuterzusammensetzung enthaltend calendula und eucalyptus für die behandlung und heilung von erkrankungen | |
DE69223152D1 (de) | Buchsbaum zubereitung für die behandlung von hiv infektion | |
AU2880495A (en) | Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses | |
BR0207931A (pt) | Anticorpos naturais ativos contra vìrus hiv | |
MY157594A (en) | Compositions of matter useful in the treatment of viral infections derived from plant extracts | |
Kumar | POSSIBLE CHARACTER OF CLASSICAL THERAPEUTIC RHIZOME OF TURMERIC FOR THE PREVENTION AND THE EXECUTIVES OF NOVEL CORONA VIRUS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1333848 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |